News

2 February

Media Release: European Public Health Advocates Demand Greater Public Returns From European Commission’s Research and Development Programme, Horizon 2020

2 February

Joint Submission to European Commission Public Consultation on Horizon 2020

18 January

HAI Response to the European Commission’s Consultation about EU Cooperation on Health Technology Assessments

18 January

Prices and Availability of Locally Produced and Imported Medicines in Ethiopia and Tanzania

18 January

Measuring Prices and Availability of Locally-produced and Imported Medicines

14 December

Media Release: Insulin Discounts Lower Price Burden for Americans, but Insulin Still Not Affordable Worldwide

12 December

Medicines Policy in Moldova

12 December

Politica cu privire la medicamente în Republica Moldova

7 December

TACD Resolution on Medicinal Products and Medical Devices in the TTIP Agreement

6 December

Fact or Fiction? What Healthcare Professionals Need to Know about Pharmaceutical Marketing

5 December

Prices and Availability of Locally Produced and Imported Medicines in Ethiopia

5 December

Prices and Availability of Locally Produced and Imported Medicines in Tanzania

30 November

Health Systems Advocacy Partnership: Fact Sheet

8 November

Health Action International Response to Report by Lancet Commission on Essential Medicines

26 October

Press Release: Health Action International Receives €460,000 Grant from Dutch Ministry of Foreign Affairs to Fight Snakebite Death & Disability in Sub-Saharan Africa

25 October

Press Release: Health Action International Launches Educational Guide to Help EU Healthcare Students & Professionals Counter Ill Effects of Pharmaceutical Marketing

17 October

Joint Letter: Civil Society Urges US Secretary Burwell to Expand Access to Patented Cancer Drugs in Developing Countries

3 October

Press Release: Report Reveals Danger Of TTIP Locking Europe & Us Into Higher Drug Prices, Failed Pharma Innovation Model

3 October

Policy Report: TTIP and Affordable Medicines – How TTIP May Obstruct Progress Towards Sustainable Access To Medicines

21 September

Media Statement: HAI Response to Political Declaration of the United Nations High-level Meeting of the General Assembly on Antimicrobial Resistance

14 September

Media Statement: Health Action International Response to Report by UN High-level Panel on Access to Medicines

13 September

Open Letter to European Commision on June 2016 EU Council Conclusions

20 July

56 Non-profit Organisations Question US State Department Pressure Against Global Access to Medicines Initiatives – Letter to US Secretary of State, John Kerry

14 July

Recommendations for EU Governments to Improve Access & Innovation of Needed Medicines

13 July

Private Patents and Public Health: Changing intellectual property rules for access to medicines

13 July

Measures That Reduced Price of Patented HIV Medicines Should Be Used to Safeguard Access to New Essential Medicines

9 June

EU Trade Policy & Access to Medicines

9 June

EU Trade Policy & Access to Medicines

3 June

HAI Provides EU Member States with Recommendations that Promote Therapeutically Advantangeous and Affordable Medicines

2 June

Civil Society Urges Member States to Defend Need for Critical Review of IP System and Incentives for Medical Innovation